You are viewing archived content
Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.
Table TDI-22. Secondary drugs cited by clients entering treatment, 2010 or most recent year available
Part (ii) Inpatient units
| Secondary drug | Number of citations by all clients | % |
|---|---|---|
| Volatile Inhalants | 391 | 1.0% |
| Hallucinogens | 494 | 1.3% |
| Other Substances | 2977 | 7.8% |
| Stimulants | 3630 | 9.5% |
| Cocaine | 3729 | 9.8% |
| Opiates | 3909 | 10.2% |
| Hypotics and Sedatives | 3998 | 10.5% |
| Alcohol | 8180 | 21.4% |
| Cannabis | 10850 | 28.4% |
| Total number of citations | 38158 | 100% |
Notes
The countries supplying data are: BE, BG, CZ, DK, IE, GR, FR, CY, LU, HU, NL, AT, RO, SK, FI, SE, UK, HR, TR.
The number of treatment clients in each country is listed in Table TDI-7.
See also 'General notes for interpreting data' on the Explanatory notes and help page.
Source:
Reitox national reports 2011 — Table TDI by centre type.